(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-10 View latest technical analysis
10 day averaged volume of Array Biopharma is 5344901
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Tue Dec 2024 | 5.86 | 6.06 | 6.06 | 5.71 | 1.585 times |
| 09 Mon Dec 2024 | 6.12 | 5.69 | 6.19 | 5.50 | 1.237 times |
| 26 Tue Nov 2024 | 6.66 | 6.94 | 6.98 | 6.53 | 0.86 times |
| 26 Tue Nov 2024 | 6.66 | 6.94 | 6.98 | 6.53 | 0.86 times |
| 25 Mon Nov 2024 | 7.02 | 6.90 | 7.24 | 6.70 | 0.769 times |
| 22 Fri Nov 2024 | 6.63 | 6.32 | 6.64 | 6.24 | 0.795 times |
| 21 Thu Nov 2024 | 6.33 | 6.33 | 6.60 | 6.22 | 0.825 times |
| 20 Wed Nov 2024 | 6.37 | 6.14 | 6.65 | 6.09 | 1.114 times |
| 19 Tue Nov 2024 | 6.10 | 6.28 | 6.30 | 5.98 | 1.196 times |
| 18 Mon Nov 2024 | 6.37 | 6.86 | 6.87 | 6.37 | 0.935 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 6.1, but if it comes above 6.1, then a intra day buy could be more profitable.
If you take a sell trade below 6.1, then use 6.1 as stoploss and 5.5 as target. However if you take a buy trade in stock , then use 6.1 as stoploss and 6.59 as target.
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 5.50 |
| Downside Target | 5.76 |
| Upside Target | 5.98 |
| Upside Target | 6.19 |
| Upside Target | 6.53 |
| Upside Target | 6.87 |
| Upside Target | 6.98 |
| Upside Target | 7.24 |
| Upside Target | 7.25 |
| Upside Target | 7.47 |
| Upside Target | 7.79 |
| Upside Target | 10.79 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 5.51 |
| Downside Intraday Target | 5.16 |
| Upside Intraday Target | 6.2 |
| Upside Intraday Target | 6.54 |
| Downside Intraday Target | 5.85 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Tue Dec 2024 | 5.86 | 5.69 | 6.19 | 5.50 | 3.283 times |
| 26 Tue Nov 2024 | 6.66 | 6.94 | 6.98 | 6.53 | 0.528 times |
| 26 Tue Nov 2024 | 6.66 | 6.90 | 7.24 | 6.53 | 0.335 times |
| 22 Fri Nov 2024 | 6.63 | 6.86 | 6.87 | 5.98 | 0.574 times |
| 15 Fri Nov 2024 | 6.85 | 6.04 | 7.79 | 5.76 | 0.548 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Tue Dec 2024 | 5.86 | 5.69 | 6.19 | 5.50 | 0.088 times |
| 26 Tue Nov 2024 | 6.66 | 6.64 | 7.79 | 5.76 | 1.439 times |
| 31 Thu Oct 2024 | 6.53 | 6.60 | 7.25 | 6.01 | 1.08 times |
| 30 Mon Sep 2024 | 6.60 | 6.66 | 7.47 | 5.56 | 0.7 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.34 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.34 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.